7Baggers
 CADL Analyst Rating: HC Wainwright & Co. Maintains 'Buy' Rating  GuruFocus Mon, 29 Sep 2025 17:12:58 GMT
 Candel trial shows promise for gene therapy in prostate cancer  Proactive financial news Mon, 29 Sep 2025 12:16:00 GMT
 cadl - candel therapeutics, inc. latest stock news & market updates  Stock Titan Mon, 29 Sep 2025 12:05:00 GMT
 Candel stock plunges 20% following Phase 2 data release  MSN Sat, 20 Sep 2025 01:13:34 GMT
 candel stock plunges 20% following phase 2 data release  MSN Fri, 19 Sep 2025 17:18:04 GMT
 Candel Therapeutics to present Phase 3 CAN-2409 data at ASTRO 2025  Proactive financial news Wed, 17 Sep 2025 07:00:00 GMT
 candel to present phase 3 prostate cancer trial data at astro meeting  Investing.com Wed, 17 Sep 2025 07:00:00 GMT
 published on: 2025-09-17 04:59:57  khodrobank.com Tue, 16 Sep 2025 13:30:45 GMT
 nuveen llc buys shares of 78,145 candel therapeutics, inc. $cadl  MarketBeat Wed, 10 Sep 2025 03:51:45 GMT
 Candel Therapeutics: Potentially The Next Exciting Oncology Story  Seeking Alpha Sun, 07 Sep 2025 07:00:00 GMT
 candel therapeutics falls after downgrade from bofa securities  MarketScreener Wed, 03 Sep 2025 19:38:16 GMT
 erasca, candle, xencor drop as bofa downgrades (eras:nasdaq)  Seeking Alpha Wed, 03 Sep 2025 19:14:48 GMT
 pattern recognition hints at candel therapeutics inc. upside  Newser Wed, 03 Sep 2025 14:34:30 GMT
 bofa securities downgrades candel therapeutics to neutral from buy  MarketScreener Wed, 03 Sep 2025 12:14:16 GMT
 candel therapeutics adds immunotherapy expert to research advisory board  Proactive financial news Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 07:27:55  beatles.ru Tue, 02 Sep 2025 04:29:08 GMT
 candel therapeutics ceo to participate in upcoming investor conferences  Proactive financial news Thu, 28 Aug 2025 07:00:00 GMT
 published on: 2025-08-27 10:17:21  Newser Wed, 27 Aug 2025 15:17:21 GMT
 published on: 2025-08-27 01:40:12  Newser Wed, 27 Aug 2025 06:40:12 GMT
 why did cadl's stock price drop?  AInvest Mon, 25 Aug 2025 07:00:00 GMT

Candel Therapeutics, Inc.
(NASDAQ:CADL) 

CADL stock logo

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of cancer immunotherapy drugs. The company offers Gene Mediated Cytotoxic Immunotherapy technology-based drugs that are designed to work with radiation, chemotherapy, and surgery t...

Founded: 1999
CEO: Paul Peter Tak  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends